Product Description
FUNCTIONS The adult human body contains approximately 1,200 g of calcium, about 99% of which is present in the skeleton, and 20-30 g of magnesium with about 60% located in bone. Bone is constantly turning over, a continuous process of formation and resorption. In children and adolescents, the rate of formation of bone mineral predominates over the rate of resorption. In later life, resorption predominates over formation. Therefore, in normal aging, there is a gradual loss of bone.
Intestinal calcium absorption ranges from 15 to 75% of ingested calcium. Vitamin D is a key regulatory hormone for calcium and bone metabolism. Adequate vitamin D status is essential for ensuring normal calcium absorption and maintenance of healthy calcium plasma levels. Magnesium absorption is independent of vitamin D status and ranges from 30 to 60% of ingested magnesium.
Osteoporosis, a condition of reduced bone mineral density that can increase risk of fractures, affects a large proportion of the elderly in developed countries. Caucasian and Asian women typically have low peak bone densities, and therefore, are at the greatest risk of developing osteoporosis. It is generally accepted that obtaining enough dietary calcium throughout life can significantly decrease the risk of developing osteoporosis. Among other factors, such as regular exercise, gender and race, calcium supplementation during childhood and adolescence appears to be a prerequisite for maintaining adequate bone density later in life. But even elderly osteoporotic patients can benefit significantly from supplementation with dietary calcium.
Calcium Complete provides a highly beneficial source of dietary calcium together with other nutrients that assist in the maintenance of healthy bone structure and function. For example, boron affects the composition, structure, and strength of bone. It appears to be necessary for calcium and magnesium absorption, their adequate renal reabsorption, and their incorporation into the bone matrix. Boron is absorbed at about 90% efficiency and is rapidly distributed among the tissues.
INDICATIONS Calcium Complete, may be a useful dietary supplement for those who wish to increase their intake of calcium and other nutritional factors for maintaining the function and structure of their bones.
SUGGESTED USE Adults take 1 tablet before each meal or as directed by physician.
SIDE EFFECTS No adverse side effects reported.
STORAGE Store in a cool, dry place, away from direct light. Keep out of reach of children.
INDICATIONS Calcium Complete, may be a useful dietary supplement for those who wish to increase their intake of calcium and other nutritional factors for maintaining the function and structure of their bones.
SUGGESTED USE Adults take 1 tablet before each meal or as directed by physician.
SIDE EFFECTS No adverse side effects reported.
STORAGE Store in a cool, dry place, away from direct light. Keep out of reach of children.
Label and Formula
FORMULA (WTX 00016)
Three Tablets Contain:
Calcium (elemental).................................................750 mg
Glutamic Acid HCl.......................................................75 mg
Lysine HCl....................................................................36 mg
Boron (Aspartate/Citrate).............................................3 mg
Vitamin D-3................................................................400 I.U.
Magnesium (elemental............................................375 mg
Vitamin C......................................................................50 mg
In a base of Silica
References
Barger-Lux MJ, Heaney RP. The role of calcium intake in preventing bone fragility, hypertension, and certain cancers. J Nutr 1994;124:1406S-1411S. Bendich A, Leader S, Muhuri P. Supplemental calcium for the prevention of hip fracture: potential health-economic benefits. Clin Ther 1999;21:1058-72.Bronner F. Calcium and osteoporosis. Am J Clin Nutr 1994;60:831-6. Bronner F, Pansu D. Nutritional aspects of calcium absorption. J Nutr 1999;129:9-12. Castelo-Branco C. Management of osteoporosis. An overview. Drugs Aging 1998;12:25-32. Celotti F, Bignamini A. Dietary calcium and mineral/vitamin supplementation: a controversial problem. J Int Med Res 1999;27:1-14. Chapin RE, Ku WW, Kenney MA, McCoy H, Gladen B, Wine RN, Wilson R, Elwell MR. The effects of dietary boron on bone strength in rats. Fundam Appl Toxicol 1997;35:205-15. Epstein O, Kato Y, Dick R, Sherlock S. Vitamin D, hydroxyapatite, and calcium gluconate in treatment of cortical bone thinning in postmenopausal women with primary biliary cirrhosis. Am J Clin Nutr 1982;36:426-30. Fleming KH, Heimbach JT. Consumption of calcium in the U.S.: food sources and intake levels. J Nutr 1994;124:1426S-1430S. Meacham SL, Taper LJ, Volpe SL. Effect of boron supplementation on blood and urinary calcium, magnesium, and phosphorus, and urinary boron in athletic and sedentary women. Am J Clin Nutr 1995;61:341-5. Meunier PJ, Delmas PD, Eastell R, McClung MR, Papapoulos S, Rizzoli R, Seeman E, Wasnich RD. Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines. Clin Ther 1999;21:1025-44. Nielsen FH. The justification for providing dietary guidance for the nutritional intake of boron. Biol Trace Elem Res 1998;66:319-30. O'Brien KO. Combined calcium and vitamin D supplementation reduces bone loss and fracture incidence in older men and women. Nutr Rev 1998;56:148-50. Patrick L. Comparative absorption of calcium sources and calcium citrate malate for the prevention of osteoporosis. Altern Med Rev 1999;4:74-85. Pines A, Raafat H, Lynn AH, Whittington J. Clinical trial of microcrystalline hydroxyapatite compound ('Ossopan') in the prevention of osteoporosis due to corticosteroid therapy. Curr Med Res Opin 1984;8:734-42. Reid IR. The roles of calcium and vitamin D in the prevention of osteoporosis. Endocrinol Metab Clin North Am 1998;27:389-98. Sojka JE, Weaver CM. Magnesium supplementation and osteoporosis. Nutr Rev 1995;53:71-4. Stellon A, Davies A, Webb A, Williams R. Microcrystalline hydroxyapatite compound in prevention of bone loss in corticosteroid-treated patients with chronic active hepatitis. Postgrad Med J 1985;61:791-6.Also Recommended
Contact us for more product recommendations!
